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Abstract 
Inflammatory bowel disease (IBD) is an important etiologic factor in the development of 
colorectal cancer. However, the mechanism underlying carcinogenesis through chronic 
inflammation is still unknown. Activation-induced cytidine deaminase (AID) is induced by the 
inflammation and involved in various human carcinogenesis via its mutagenic activity. In the 
current study, we investigated whether the inflammation/AID axis plays an integral role in the 
development of colitis-associated cancers. Inflammation in the cecum was more severe than 
that in other colonic regions, and endogenous AID expression was enhanced most prominently 
in the inflamed cecal mucosa of interleukin (IL)-10
-/-
 mice. Blockade of tumor necrosis factor 
(TNF)- and IL-12 significantly suppressed AID expression. Although proinflammatory 









sequencing analyses revealed a significantly lower incidence of somatic mutations in Trp53 
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 mice developed cancers except only one case of neoplasia in the distal 
colon. These findings suggest that the proinflammatory cytokine-induced aberrant production 
of AID links colonic inflammation to an enhanced genetic susceptibility to oncogenic 
mutagenesis. Targeting AID could be a novel strategy to prevent colitis-associated colon 
carcinogenesis irrespective of ongoing colonic inflammation. 
 






Chronic inflammation in epithelial tissues predisposes to the development of cancers 
(Mantovani et al., 2008). For example, epidemiologic studies demonstrate that patients with 
chronic hepatitis caused by hepatitis virus infection and chronic gastritis caused by Helicobacter 
pylori infection leads to the development of hepatocellular carcinoma and gastric cancers, 
respectively (Chiba et al., 2006; Ikeda et al., 2007). Similarly, it is well recognized that the 
incidence of colorectal cancer is significantly higher in those with inflammatory bowel disease 
(IBD) than in the general population (Podolsky, 2002). Indeed, the cumulative risk of developing 
colorectal cancer for any patient with ulcerative colitis is estimated to be 1.6% at 10 years, 8.3% 
at 20 years, and 18.4% at 30 years from disease onset (Eaden et al., 2001). The mechanisms of 
colon carcinogenesis in chronically inflamed tissue remain unclear, but it is reasonable to assume 
that multistep gene alterations required for malignant transformation occur in the constitutively 
inflamed colonic mucosa. Consistent with this idea, genetic alterations such as the TP53 
mutation appear to be an early event and are already present in colonic mucosa of patients with 
ulcerative colitis before cancer onset (Hussain et al., 2000; Kern et al., 1994; Leedham et al., 
2009; Yin et al., 1993). Therefore, identifying the molecular pathway that links inflammation and 
genetic alterations in tumor-related genes is an important step to understand colitis-associated 
carcinogenesis. 
Recently, we demonstrated that one of a human nucleotide-editing enzyme, activation-induced 
cytidine deaminase (AID), induces somatic mutations in several tumor-related genes, including 
TP53, in gastrointestinal epithelial cells (Endo et al., 2007; Endo et al., 2008; Komori et al., 
2008; Kou et al., 2007; Matsumoto et al., 2007). AID was originally identified as an inducer of 
somatic mutations and class switch recombination of immunoglobulin genes, which diversifies 
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the antibody production in B lymphocytes (Muramatsu et al., 2000). Although AID expression is 
restricted to activated B cells under physiologic conditions, the inflammatory response can 
trigger aberrant AID expression in various epithelial organs. Stimulation of proinflammatory 
cytokines such as tumor necrosis factor (TNF)- induces AID expression in hepatocytes, 
cholangiocytes, and gastric epithelial cells (Endo et al., 2007; Komori et al., 2008; Matsumoto et 
al., 2007). More importantly, aberrant AID expression in these epithelial cells results in the 
generation of nucleotide alterations in tumor-related genes and possible malignant transformation 
of the AID-expressing cells. Consistent with this hypothesis, animal models with constitutive and 
ubiquitous AID expression revealed that AID expression in epithelial tissues results in the 
accumulation of genetic mutations in various genes, leading to the development of liver, lung 
and gastric cancers (Morisawa et al., 2008; Takai et al., 2009). These findings strongly suggest 
that AID nucleotide-editing activity is intimately involved in the pathogenesis of 
inflammation-associated carcinogenesis (Chiba and Marusawa, 2009).  
Chronic production of various proinflammatory cytokines is thought to be responsible for 
tumor development and progression in colitis-associated cancers (Lin and Karin, 2007). One 
example of the oncogenic effect of proinflammatory cytokines on colonic cells is provided by the 
colon carcinogenesis model, in which TNF- blockade reverses azoxymethane and dextran 
sodium sulfate-induced colonic mucosal damage and attenuates subsequent colon cancer 
development (Popivanova et al., 2008). What is noteworthy is that aberrant AID expression is 
induced in colonic epithelial cells in response to TNF- via the IB kinase-dependent nuclear 
factor (NF)-B signaling pathways (Endo et al., 2008). Moreover, we showed that enhanced 
expression of endogenous AID protein is detectable in the inflamed colonic mucosa of patients 
with ulcerative colitis or Crohn’s disease (Endo et al., 2008). These findings suggest that the 
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inflammatory cytokine/AID axis may actually promote colon carcinogenesis by its genotoxic 
activity in the background of IBD. To clarify whether AID is a crucial mediator of the genetic 
alterations required for inflammation-mediated carcinogenesis, we investigated the impact of 
AID deficiency in the pathogenesis of colitis-associated colon cancer.  
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Results 
AID gene expression in inflamed colonic mucosa of interleukin (IL)-10
-/- 
mice 
We first investigated endogenous AID expression in association with the degree of colonic 
inflammation in IL-10
-/-
 mice, a representative model of human IBD. IL-10
-/-
 mice were 
maintained under pathogen-free conditions and histologic analysis was performed using 
paraffin-embedded tissue sections from the cecum, the proximal colon, the distal colon and the 
small intestine. IL-10
-/-
 mice spontaneously developed intestinal inflammation after 8 weeks of 
age, whereas no inflammatory change was observed in the colons of the wild-type (WT) mice 
(Figure 1a). In 52-week-old IL-10
-/-
 mice, the histologic findings from the colonic tissue revealed 
epithelial hyperplasia, inflammatory cell infiltration, and goblet cell loss (Figure 1a). 
Inflammatory lesions occurred at greater severity in the cecum compared with the proximal 
colon, the distal colon and the small intestine. 
Colonic mucosal inflammation in IL-10
-/-
 mice is mediated by proinflammatory cytokines as 
well as an excessive Th1 T-cell response associated with increased inteferon (IFN)- and IL-12 
secretion (Berg et al., 1996; Davidson et al., 1996). Consistent with previous studies, expression 
levels of proinflammatory cytokines such as TNF-, IL-1, and IL-6 were elevated in the 
inflamed cecal mucosa of the 52-week-old IL-10
-/- 
mice (Figure 1b). Moreover, enhanced 
expression of Th1 cytokines, including IL-12 and IFN-, was observed in the 52-week-old 
IL-10
-/-
 mice, but little expression of inflammatory cytokines was detected in 8-week-old IL-10
-/-
 
mice. In contrast, the expression levels of Th2 cytokines such as IL-4 and IL-13 did not differ 
between control and the IL-10
-/-
 mice (Figure 1b). 
 We next examined whether aberrant AID expression appeared in association with colonic 
inflammation in IL-10
-/-
 mice. Quantitative RT-PCR revealed a marked elevation of endogenous 
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AID expression in the cecal epithelial cells of IL-10
-/- 
mice older than 20 weeks of age, whereas 
only trace amounts of AID expression in younger IL-10
-/-
 mice and in WT mice (Figure 1c, 
Supplementary Figure 1). In the 20- and 52-week-old IL-10
-/-
 mice, AID was strongly expressed 
in the cecal mucosa compared with the epithelium of the proximal and distal colon (Figure 1d).  
 To determine whether the increased AID expression derives from epithelial cells or infiltrating 
B lymphocytes, we examined the expression pattern of endogenous AID in the inflamed cecal 
mucosa of IL-10
-/-
 mice using in situ hybridization (ISH). The specificity of the ISH results was 
confirmed by control staining performed on an intestinal lymphoid follicle containing mostly 
activated B cells or the tissues derived from the transgenic mice with constitutive AID expression 
(Figure 1e, Supplementary Figure 2). No AID expression was detected in the normal cecal 
mucosa, liver and kidney of WT mice, or the murine B lymphoma cells with the 
siRNA-mediated knock down of endogenous AID transcripts (Figure 1e, Supplementary Figure 
2). In contrast, high AID expression was observed mainly in cytoplasm of both the cecal 
epithelium and lymphocytes in inflamed intestinal tissues (Figure 1e, Supplementary Figure 3). 
These findings suggest that persistent inflammation in the cecum of the older IL-10
-/-
 mice is 
closely associated with the enhanced production of various inflammatory cytokines, leading to 
the induction of aberrant AID expression in inflamed colonic mucosa. 
 




To clarify the role of TNF- and IL-12 in the pathophysiology of colonic inflammation in 
association with aberrant AID expression in the IL-10
-/-
 mice, the biologic activity of TNF- and 
IL-12 was inhibited using the TNF antagonist etanercept and neutralizing IL-12p40 monoclonal 
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antibody (mAb), respectively (Liu et al., 2006; Popivanova et al., 2008; Watanabe et al., 2006). 
First, we confirmed that both TNF- and IL-12 expression were significantly upregulated in the 
cecum compared with the proximal and distal colon (P<0.05, Figure 2a). In agreement with 
established findings that TNF- augments the expression of various cytokines and chemokines 
(Marra et al., 1993; Popivanova et al., 2008), etanercept treatment resulted in the suppression of 
a variety of proinflammatory cytokines and chemokines such as TNF-, IL-12, IFN, IL-1 IL6, 
and monocyte chemoattractant protein-1 (MCP-1) (Figure 2b, Supplementary Figure 4). In 
contrast, there was no apparent difference in the expression levels of IL-5, a Th2 cytokine, 
between the etanercept and control groups (Supplementary Figure 4). Histopathologic findings 
revealed that the cecal inflammation was substantially reduced in mice treated with etanercept 
compared with the control mice (Figure 2c, left and middle panels). Similar to etanercept, 
IL-12p40 mAb treatment effectively suppressed cecal inflammation in association with reduced 
levels of proinflammatory cytokines and chemokines other than IL-5 compared with the control 
mice (Figure 2b, Supplementary Figure 4).  
NF-B p65 is strongly activated in the inflamed colonic mucosa of IL-10-/- mice (Inoue et al., 
2009; Neurath et al., 1996). To determine the effect of inhibition of the TNF-- or 
IL-12-mediated signaling pathways on NF-B activity, immunohistochemical staining of the 
cecal tissue from IL-10
-/-
 mice was performed using the phospho-NF-B p65 antibody. In the 
vehicle-treated IL-10
-/-
 mice, phospho-NF-B p65 was strongly positive in the nucleus of the 
epithelial cells, whereas NF-B activation was markedly suppressed in the cecal mucosa of mice 
treated with the etanercept or IL-12p40 mAb (Figure 2c, right panels).   
Endogenous AID expression is induced in response to TNF- or IL-12 treatment and AID 
transcription is regulated via IB kinase-dependent NF-B signaling pathways in human colonic 
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cells (Endo et al., 2008). Thus, we investigated AID expression levels when TNF- or IL-12 
activity was inhibited in the colonic tissue of IL-10
-/-
 mice. Quantitative RT-PCR analyses 
showed that endogenous AID expression was markedly decreased in the cecal mucosa both in the 
etanercept group and the IL-12p40 mAb group compared with the control group (Figure 2d). 
These findings suggest that TNF- and IL-12 play a critical role in not only intestinal 




AID deficiency did not affect the expression levels of proinflammatory cytokines in colonic 
mucosa. 
 To gain insight into the role of AID expression in the inflamed colonic mucosa, we evaluated 
the effect of AID deficiency on the inflammatory response by crossing AID
-/-
 mice with IL-10
-/-
 




 mice were subjected to further 





including pronounced inflammatory infiltration and marked epithelial hyperplasia, were 




 littermates (Figure 3b). In agreement with a previous 
study (Fagarasan et al., 2002), hyperplasia of isolated lymphoid follicles developed in the cecum 
of 52-week-old AID
-/-




 mice (data not shown). RT-PCR analyses 
revealed only trace amounts of cytokine expression in WT or AID
-/-
 mice (Figure 3c). In contrast, 
enhanced expression levels of various cytokines such as TNF-, IL-12, IFN, IL-1 and IL-6 









(Figure 3c). Quantitative RT-PCR analyses also showed markedly enhanced expression levels of 









(Figure 3d). Thus, the production levels of inflammatory cytokines and chemokines in the cecal 
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Deficiency of endogenous AID resulted in the reduced frequencies of nucleotide alterations 
in the Trp53 gene in IL-10
-/-
 mice. 
To clarify whether the AID upregulation induced by chronic colitis is genotoxic in colonic 
mucosa, we determined the nucleotide sequences of the Trp53, Apc, Ctnnb1 and Kras genes, all 
of which are thought to be involved in human colorectal carcinogenesis (Fearon and Vogelstein, 
1990). We first confirmed that the incidence of nucleotide alterations was less than 1.00 
substitution per 10
4
 nucleotides in these 4 tumor-related genes obtained from over 40 randomly 
picked clones from the normal cecal epithelial cells of WT mice, determined by conventional 
sequencing analyses with high-fidelity PCR amplification (data not shown). We then determined 
the sequences of the Trp53, Apc, Ctnnb1 and Kras genes in 50 randomly selected clones 









(Representative data is shown in Table 1.). Nucleotide alterations had accumulated in the Trp53 




 mice with a frequency of 2.19 
substitutions per 10
4
 nucleotides (Table 1). Although all the nucleotide changes determined in the 
Trp53 gene were different in each clone, 9 of 12 (75%) alterations were accumulated in the 
regions corresponding to the DNA-binding motif of the human TP53 gene (Figure 4). Among the 




 mice, 7 (58.3%) of 12 
genetic changes were single-base substitutions and 4 of these 7 alterations in the Trp53 coding 
sequences resulted in amino acid replacements with potential functional consequences. In 





mice (0.71 substitutions per 10
4






mice (P<0.05, Table 1). On the other hand, the Apc, Ctnnb1 and Kras genes did not have 





mice, and thus the incidence of nucleotide changes in the Apc, Ctnnb1 and Kras genes was not 








mice (Table 1). These findings 
suggest that the Trp53 gene is a specific target gene in chronically inflamed cecal mucosa in 
IL-10
-/-
 mice, and the accumulation of genetic changes in the Trp53 gene of the inflamed colonic 
mucosa was due to AID activity. 
 
The incidence of colon cancer was reduced in IL-10
-/-
 mice in the absence of endogenous 
AID. 
The findings that AID deficiency in IL-10
-/-
 mice had no significant impact on the levels of 
colonic inflammation but reduced the frequencies of somatic mutations in the tumor-suppressor 
Trp53 gene led us to speculate that the knockout of endogenous AID might reduce the incidence 
of colonic cancer development irrespective of ongoing colonic inflammation. Thus, we compared 








 mice. The 









 mice are summarized in Table 2. Dysplastic changes in the mucosa of the large 
intestine were equally observed in most of these mice. These dysplastic lesions more frequently 
developed in the cecum than in the proximal and distal colon. Interestingly, invasive 




 mice and all the tumors 
characteristically developed from the dysplastic mucosa in the cecum (Table 2). Histopathologic 
analysis of colonic tumors revealed moderate- to poorly-differentiated adenocarcinomas and 
invasive tumor cells beyond the submucosa with strong -catenin expression (Figure 5a, 
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 mouse developed no tumors in the inflamed 
colonic mucosa except only one tumor in the distal colon (Table 2). The colonic tumor that 




 mouse showed a trabecular pattern of growth within the 
submucosa, consistent with the morphologic appearance of well-differentiated adenocarcinoma 
(Figure 5b). These findings suggest that the upregulation of endogenous AID in the cecal mucosa 
driven by the inflammatory response contributes to the development of colonic cancers. 
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Discussion 
The causal association between colonic inflammation and carcinogenesis is now well 
recognized (Eaden et al., 2001; Podolsky, 2002). A recent genetic-linkage analysis of patients 
with IBD revealed that loss-of function mutations in genes encoding the IL-10 receptor proteins 
are associated with severe, early-onset enterocolitis, a finding that underscores the pivotal role of 
IL-10 in mediating the signals that control inflammation in the human gut (Glocker et al., 2009). 
Consistent with the clinical finding, a mouse model with targeted disruption of the IL-10 gene 
invariably develops enterocolitis that eventually progresses to colon cancer under conventional 
housing conditions; this mouse model is thus extremely useful as a disease model of human IBD 
(Berg et al., 1996; Kuhn et al., 1993; Sturlan et al., 2001). In the present study, expression of 
AID was most prominent in the inflamed cecal mucosa of IL-10
-/-
 mice. Moreover, we 
demonstrated that a deficiency of endogenous AID reduces the incidence of both the 
accumulation of somatic mutations in the Trp53 gene and the development of colon cancer in 
inflamed colonic mucosa. In vitro, we previously demonstrated that aberrant AID expression is 
induced in response to proinflammatory cytokine stimulation and colonic epithelial cells 
underlying chronic inflammation acquire the genetic mutations achieved by AID genotoxic 
activity (Endo et al., 2008). Together, these findings suggest that inappropriate AID expression 
plays a pivotal role in the development of colorectal cancers via the accumulation of genetic 
alterations in the colonic mucosa of IBD.  
We revealed here that endogenous AID is upregulated in inflamed colonic mucosa of elder 
IL-10
-/-
 mice and the degree of AID expression paralleled extent of colonic inflammation. This 
observation is consistent with the findings that AID protein expression was detected in the 
colonic epithelium of inflammatory lesions from patients with IBD (Endo et al., 2008). Colonic 
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mucosal inflammation is usually mediated by either an excessive Th1 T-cell response associated 
with increased IFN- and IL-12 secretion, or an excessive Th2 T-cell response associated with 
increased IL-4, IL-5, and IL-13 secretion (Fuss et al., 1996). We previously found that the 
proinflammatory cytokine TNF-, the Th2 cytokines IL-4 and IL-13, and Th1 cytokine IL-12 
enhanced aberrant AID expression in cultured colonic epithelial cells (Endo et al., 2008). On the 
other hand, TNF- expression is elevated in colonic tissues of IL-10-/- mice (Berg et al., 1996), 
and colitis in IL-10
-/-
 mice is predominantly mediated by Th1 type T cells with increased 
production of IL-12 (Berg et al., 1996; Davidson et al., 1996). Consistent with these previous 
findings, in the present study blockade of the activity of TNF- or IL-12 suppressed AID 
expression in association with reduced production of various pro-inflammatory cytokines in the 
inflamed colonic mucosa of IL-10
-/-
 mice. Thus, it is reasonable to assume that cytokine 
signalings, especially those mediated by TNF- and IL-12, contribute to aberrant AID expression 
in the colonic cells of IL-10
-/-
 mice. 
A causal relationship between colonic inflammation and the accumulation of TP53 
tumor-suppressor gene mutations has been reported in human IBD (Hussain et al., 2000; Kern et 
al., 1994; Leedham et al., 2009; Yin et al., 1993). Alterations in the TP53 gene, a late event in 
the pathogenesis of sporadic colorectal cancers, occur in dysplastic lesions with a background of 
ulcerative colitis (Holzmann et al., 1998; Yin et al., 1993) and are likely to proceed to dysplasia 
(Lashner et al., 1999). Thus, the increased TP53 mutation load in inflamed colonic epithelium of 
patients with IBD suggests that TP53 mutations in noncancerous colon tissue of IBD patients 
specifically confer susceptibility to the development of colorectal cancers in an inflammatory 
microenvironment (Hussain et al., 2000). In the present study, we found that high frequencies of 






 mice. In addition, we demonstrated that a deficiency of endogenous AID in 
inflamed colonic mucosa resulted in a significantly reduced occurrence of somatic mutations in 
the Trp53 genes, while there was no significant accumulation of somatic mutations appeared in 









 mice. It is unclear why the Trp53 gene was more sensitive to 
AID-mediated genotoxic activity than the Apc, Ctnnb1 and Kras genes in colonic epithelial cells 
of IL-10
-/-
 mice. The present findings, however, are consistent with a previous observation that 
target gene selection for AID-induced somatic mutations varies among tissues and target cells 
(Morisawa et al., 2008) and AID expression in cultured human colonic epithelial cells 
preferentially targets the TP53 gene in vitro (Endo et al., 2008). On the other hand, alterations in 
the APC and KRAS genes are also detected in dysplastic lesions and cancer tissues that develop 
in human IBD (Redston et al., 1995). Therefore, we assume that the mutations in APC, CTNNB1, 
and KRAS genes were also present, but that their frequencies were below the detection limits of 
the present study. Further comprehensive sequencing analyses are required to determine how the 
AID-mediated genotoxic effects achieve the target gene selection and whether IL-10
-/-
 mice and 
human IBD share a similar process of mutational accumulation in tumor-related genes.  
It is noteworthy that AID deficiency resulted in the reduced incidence of colitis-associated 
colon cancer development. AID deficiency caused the development of hyperplasia of isolated 
lymphoid follicles associated with an expansion of anaerobic flora in the small intestine 
(Fagarasan et al., 2002; Suzuki et al., 2004). We found no significant differences in the 









 mice. This observation might be consistent with the previous findings that 




mice, as evidenced by their ability to transfer colitis to immunodeficient RAG2
-/-
 mice (Davidson 
et al., 1996). In contrast to the similar levels of colonic inflammatory activity, the incidence of 









mice harboring endogenous AID. It may be emphasized that expression levels of endogenous 
AID in the cecal mucosa was significantly higher than those of the remaining sites of the colon 




 mice were located at the cecum, while 









developed a tumor in the distal colon. Histologic examination indicated that this tumor had the 
morphologic appearance of well-differentiated adenocarcinoma located within the submucosa, 




 mice invaded the muscularis propria or 
adventitia with the characteristics of moderate- to poorly-differentiated adenocarcinoma. Based 
on the above discussion, ectopic AID expression in the inflamed colonic mucosa is an 
indispensable factor for the development of colon cancers in IL-10
-/- 
mice.  
Recent studies revealed that AID is involved in regulating DNA methylation in certain 
systems (Bhutani et al., 2010; Guo et al., 2011; Rai et al., 2008). Moreover, infiltrating 
leukocytes, including B cells, might modulate tumor cell properties via the production of certain 
chemokines or cytokines (Ammirante et al., 2010). Therefore, further studies are necessary to 
examine the incidence of inflammation-associated cancers in mice in which AID is specifically 
deficient in the epithelial cells, and to clarify whether AID has a role in inflammation-associated 
tumorigenesis through the epigenetic modification of tumor-related genes. 
In conclusion, we demonstrated that the proinflammatory cytokine TNF- and the Th1 
cytokine IL-12 are responsible for aberrant AID expression in the colonic mucosa of IL-10
-/- 
mice with chronic inflammation. Aberrant AID expression in the inflamed colon is associated 
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with the accumulation of somatic mutations in tumor suppressor Trp53 gene, and AID deficiency 
resulted in a reduced incidence of colitis-associated colon cancers. These findings may lead to a 
novel strategy for preventing carcinogenesis by targeting AID irrespective of the ongoing colonic 
inflammation in patients with IBD. 
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Materials and Methods 
Animal experiments 
The generation of AID
-/-
 mice was described previously (Fagarasan et al., 2001). IL-10
-/- 
mice 
(The Jackson Laboratory, Bar Harbor, ME) and AID
-/-
 mice were crossed on a C57BL/6 




 mice. All mice were maintained in a specific pathogen-free 
facility at Kyoto University Faculty of Medicine. Cecal and colonic epithelium was purified as 
follows; Cecum and colon were cut into 2.0cm long and incubated with 2mM EDTA in Hank’s 
Balanced Salt Solution without calcium and magnesium for 10 minutes at room temperature. 
Then, the tissues were tumbled for 6 minutes and the mucosa was selectively stripped from the 
submucosa. The stripped mucosa was washed with phosphate buffered saline (PBS) for three 
times and the supernatant containing floating cells and debris were discarded. The obtained 
epithelial tissue samples and non-epithelial tissue samples were frozen in liquid nitrogen for 
nucleotide extraction. In some experiments, IL-10
-/-
 mice were intraperitoneally injected with 
TNF antagonist etanercept and neutralizing antibody to murine IL-12p40 (Watanabe et al., 2006). 
Accordingly, 40-week-old IL-10
-/-
 mice were injected with etanercept at a dose of 3 mg/kg body 
over 5 days and killed on day 12. Other 40-week-old IL-10
-/-
 mice were injected with IL-12p40 
mAb at a dose of 0.5 mg/body on day 1 and day 8, and sacrificed at day 12. All animal 
experiments were approved by the Ethics Committee for Animal Experiments and performed 
under the Guidelines for Animal Experiments of Kyoto University. 
Histopathologic and immunohistochemical analyses 
The entire colon was removed and washed with PBS. The cecum, the proximal colon and the 
distal colon were dissected transversely and fixed in 4% (w/v) formaldehyde. The fixed tissue 
was embedded in paraffin and sectioned at 3 m in a random manner. In particular, two types of  
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histologic preparations were sectioned from the tissues of the cecum. These samples were stained 
with hematoxylin and eosin and analyzed histologically in a blind fashion by three readers. 
Immunohistochemical staining was performed according to a previously described protocol 
(Toda et al., 1999). The polyclonal antibodies for phospho-NF-B p65 (Ser276) and -catenin 
were purchased from Cell Signaling Technology (Danvers, MA) and BD Biosciences (Franklin 
Lakes, NJ), respectively. 
In situ hybridization 
A digoxigenin-labeled RNA probe specific for murine AID was transcribed with 
digoxigenin-11-UTP according to the manufacturer’s instructions (Roche, Basel, Switzerland) 
from a 1.7-kb cDNA amplified using the following primers: 5’-ATG GAC AGC CTT CTG GTG 
ATG AA-3’ and 5’-CTT GTT CCC AAG GTC GCA AGG AAA GG-3’. Similarly, an RNA probe 
for murine villin1 was transcribed from a 1.6-kb cDNA amplified using the following primers: 
5’- TGA ATG CCC AAC TCA AAG GCT CTC TC-3’ and 5’-ACC TCA AAA GCC TTG GTG 
TTA TCA GC-3’. In situ hybridization was performed as described previously (Nakatani et al., 
2004). The alkaline phosphatase chromogen reaction was performed using Fast Red (Roche) as 
the substrate at room temperature for 48 hours. The sections were then washed with distilled 
water and mounted on glass slides in mounting medium. 
Semiquantitative and quantitative reverse transcription-polymerase chain reaction (RT-PCR) 
Total RNA was extracted from the tissues using QuickGene RNA Tissue Kit (Fuji, Tokyo, Japan). 
cDNA was synthesized using Transcriptor First Strand cDNA Synthesis Kit (Roche). PCR 
amplification was performed using Takara Ex Taq DNA polymerase (Takara, Tokyo, Japan). The 
oligonucleotide primers for the semiquantitative RT-PCR are shown in Supplementary Table 1. 
Gene expression was quantified by quantitative real-time RT-PCR using LightCycler 480 System 
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II (Roche). The oligonucleotide primers for the quantitative RT-PCR are shown in 
Supplementary Table 2. To assess the quantity of isolated RNA as well as the efficiency of cDNA 
synthesis, target cDNAs were normalized to the endogenous mRNA levels of the housekeeping 
reference gene 18S rRNA (Matsumoto et al., 2007). For simplicity, ratios are represented as 
relative values compared with expression levels in lysate from control specimens. 
Subcloning and sequencing analyses of tumor-related genes 
The oligonucleotide primers for the amplification of the murine Trp53, Apc, Ctnnb1 and Kras 
genes are shown in Supplementary Table 3. Amplification of targeted sequences was performed 
using high-fidelity Phusion Taq Polymerase (Finnzymes, Espoo, Finland), and the products were 
subcloned using pGEM-T Easy Vector Systems (Promega, Madison, WI). The resulting plasmids 
were subjected to sequence analysis using Applied Biosystems 3500 Genetic Analyzer (Life 
Technologies, Carlsbad, CA). 
Statistical analysis 
Statistical analysis was performed using a Mann-Whitney U test, a chi-square test and Fisher’s 
test. Differences were considered to be statistically significant if P values were less than 0.05. 
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Figure 1. Endogenous AID expression in inflamed colonic mucosa of IL-10
-/-
 mice. (a) 
Microscopic (hematoxylin and eosin (H&E) stain) images of the cecum of IL-10
-/-
 mice and its 
WT littermate. The images of 8-week-old mice (i,iii) and 52-week-old mice (ii,iv) are shown. 
Scale bars are 200m. (b) Representative results of RT-PCR for the expression of various 
proinflammatory cytokines in the cecal mucosa of IL-10
-/-
 mice. Total RNA was extracted from 
cecal mucosa of 8- and 52-week-old IL-10
-/-
 mice and their WT littermates. RT-PCR was 
performed using oligonucleotides specific for murine TNF-, IL-12, IFN-, IL-1, IL-6, IL-4, 
IL-13, and -actin. (c) Time course changes of AID expression in the cecal mucosa of IL-10-/- 
mice. Total RNA was isolated from mucosa at the cecum of 8-, 12-, 20-, and 52-week-old IL-10
-/-
 
mice and WT littermates of 52-week-old IL-10
-/- 
mice. Quantitative RT-PCR was performed 
using oligonucleotides specific for murine AID. *P<0.05 versus WT mice. (d) AID expression in 
various regions of colonic mucosa of IL-10
-/-
 mice. Total RNA was extracted from mucosa at the 
cecum, and the proximal and distal colon of 52-week-old IL-10
-/-
 mice and WT littermates. 
Quantitative RT-PCR was performed using oligonucleotides specific for murine AID. *P<0.05. 
(e) Representative images of AID expression in inflamed cecal mucosa determined by in situ 
hybridization assay. The images show the intestinal lymphoid follicle (left panels), the cecal 
mucosa of WT (middle panels) and IL-10
-/-
 mice (right panels) stained with H&E (upper panels) 
or hybridized with the probe specific for the murine AID transcript (lower panels). Scale bars are 
100m. 
 
Figure 2. Effects of TNF- and IL-12 blockade on various cytokine expression, NF-B 
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activation, and AID expression in the colonic mucosa of IL-10
-/-
 mice. (a) TNF- and IL-12 
expression in various regions in colonic mucosa of IL-10
-/-
 mice. Total RNA was extracted from 
mucosa at the cecum, and the proximal and distal colon of 52-week-old IL-10
-/-
 mice and the 
cecum of the WT littermates. Quantitative RT-PCR was performed using oligonucleotides 
specific for murine TNF- and IL-12. *P<0.05. (b) Changes of various cytokine expression 
under the inhibition of the biologic activity of TNF- and IL-12. Total RNA was isolated from 
mucosa at the cecum of IL-10
-/-
 mice treated with PBS, etanercept, and IL-12p40 mAb. 
Quantitative RT-PCR was performed using oligonucleotides specific for murine TNF- and 
IL-12. Relative values of these cytokines are shown. *P<0.05 versus control mice. (c) Changes 
of histopathologic image and NF-B activation induced by administration of etanercept and 
IL-12p40 mAb. Microscopic images (H&E stain) of the cecum of IL-10
-/-
 mice treated with PBS 
(i,ii), etanercept (iv,v) and IL-12p40 mAb (vii,viii). Immunohistochemical staining for 
phospho-NF-B p65 was performed using each sample including control group (iii), 
etanercept-treated group (vi), and IL-12p40 mAb-treated group (ix). Scale bars are 500m. (d) 
Results of quantitative RT-PCR for AID expression in the cecum of IL-10
-/-
 mice treated with 
PBS, etanercept, and IL-12p40 mAb. *P<0.05 versus control mice. 
 
Figure 3. Effects of AID-deficiency in the colonic mucosa of IL-10
-/-
 mice. (a) Results of 
quantitative RT-PCR for AID expression. Total RNA was extracted from the mucosa at the 








 mice. Quantitative 
RT-PCR was performed using oligonucleotides specific for murine AID. *P<0.05 versus WT 









 mice. Upper panels (i,iii) are the images of the cecum and lower panels 
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(ii,iv) are the images of the distal colon. Scale bars are 200m. (c) Representative results of 
semiquantitative RT-PCR for the expression of various proinflammatory cytokines in the cecum 










 mice.  RT-PCR analyses were 
performed by using specific primers for murine TNF-, IL-12, IFN-, IL-1, IL-6, IL-4, IL-13, 
and -actin. (d) Results of quantitative RT-PCR for MCP-1 expression in the cecum of each 
genotype. *P<0.05 versus WT mice. 
 









 mice. Murine p53 codon numbers are shown with equivalent human p53 
domain structure with transactivation (TAD), DNA-binding and tetramerization (tetramer) 
domains and nuclear localization signal (NLS). 
 
Figure 5.  Colonic adenocarcinomas developed in IL-10
-/-
 mice. (a) Microscopic images (H&E 




 mice (i-vi). Scale bars 
are 500m. (b) Microscopic images (H&E stain) of adenocarcinoma developed in the distal 




 mouse (i,ii). Scale bars are 500m.
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Trp53 AID (+/+) 12/54,787 2.19 
<0.05 
 AID (-/-) 5/70,380 0.71 
Apc AID (+/+) 2/33,717 0.59 
0.43 
 AID (-/-) 1/42,762 0.23 
Ctnnb1 AID (+/+) 5/38,988 1.28 
0.51 
 AID (-/-) 2/36,037 0.55 
Kras AID (+/+) 4/36,603 1.09 
0.84 
 AID(-/-) 3/31,955 0.94 
 
Representative results of mutation frequencies in Trp53, Apc, Ctnnb1 and Kras genes in inflamed 








 mice are shown.  
* Number: number of mutated nucleotides / number of total nucleotides examined. 
** P value is calculated using a chi-square test. 
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Mean age (weeks) 54.5 51.2 
Male / Female 13 / 9 13 / 10 
Tumor formation   
Adenoma 20 (90.9%) 21 (91.3%) 
Cecum 20 20 
Proximal colon 1 1 
Distal colon 13 16 
Adenocarcinoma 6* (27.2%) 1* (4.3%) 
Cecum 6 0 
Proximal colon 0 0 
Distal colon 0 1 
 
Values in parenthesis show percentages of animals that developed adenoma or 
adenocarcinoma. 
* P<0.05 (P value is calculated using Fisher’s test) 









Supplementary Materials and Methods 
RNA interference 
Stealth siRNA specific for AID (5’- AAA GGA UGC GCC GAA GUU GUC UGG U 
-3’) was obtained from Invitrogen (Carlsbad, CA). The Stealth siRNA was introduced 
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Supplementary Figure 1. Takai et al.
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IL-10-/-WT 
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Supplementary Table 1.   Primer sequences used for semiquantitative RT-PCR amplification 
 
 







IL-1β-161S 5’- GAAGGGCTGCTTCCAAACCT-3’ 
IL-1β-616AS 5’- TTCTTTCCTTTGAGGCCCAAG-3’ 
IL-6-95S 5’- ACCACGGCCTTCCCTACTTC-3’ 
















Primer Nucleotide sequence 
AID-93S 5’-CGTGGTGAAGAGGAGAGATAGTG-3’ 
AID-203AS 5’-CAGTCTGAGATGTAGCGTAGGAA-3’ 
TNF-α-181S 5’- GACGTGGAACTGGCAGAAGAG-3’ 
TNF-α-325AS 5’- CGATCACCCCGAAGTTCAGTAG-3’ 
IL-12-419S 5’- GCCAGTACACCTGCCACAAAG-3’ 
IL-12-566AS 5’- CCGGAGTAATTTGGTGCTTCAC-3’ 
IFN-γ-133S 5’- GCTTTGCAGCTCTTCCTCATG-3’ 
IFN-γ-282AS 5’- TTGCCAGTTCCTCCAGATATCC-3’ 
IL-1β-316S 5’- CCTTCCAGGATGAGGACATGAG-3’ 
IL-1β-462AS 5’- GTTGTTCATCTCGGAGCCTGTAG-3’ 
IL-6-57S 5’- TCCATCCAGTTGCCTTCTTG-3’ 
IL-6-221AS 5’- CCACGATTTCCCAGAGAACA-3’ 
MCP-1-193S 5’-CAGGTCCCTATGGTGCCAAT-3’ 
MCP-1-343AS 5’-TCTCGGTTCTTGACGGTTATCA-3’ 
IL-5-113S 5’- CCCATGAGCACAGTGGTGAA-3’ 
IL-5-237AS 5’- TCTCCAATGCATAGCTGGTGAT-3’ 
18S rRNA-S 5’-TAGAGTGTTCAAAGCAGGCCC-3’ 
18S rRNA-AS 5’-CCAACAAAATAGAACCGCGGT-3’ 
 1





Primer Nucleotide sequence 
Apc-1852S 5’-CTCACTTACCGGAGCCAGAC-3’ 
Apc-2703AS 5’-GTCGTCCTGGGAGGTATGAA -3’ 
Apc-3735S 5’-TACTTGCAAAGTCCCCTCCA -3’ 
Apc-5021AS 5’-CTGACCCCATCTCCAGTAGC -3’ 
Ctnnb1-S 5’-CTGTTCTACGCCATCACGAC-3’ 
Ctnnb1-AS 5’-ATGGTGGGTGCAGGAGTTTA-3’ 
Kras-S 5’-AGGCCTGCTGAAAATGACTG -3’ 
Kras-AS 5’-ACACCTTGTCCTTGACTTCTTC-3’ 
Trp53-S 5’-ATGACTGCCATGGAGGAGTCA -3’ 
Trp53-AS 5’-AGAGGCAGTCAGTCTGAGTCA -3’ 
